Evidence map›Paper›PMID 30343342›Full record

ArticleClinical rheumatology2019

IgG levels in Kawasaki disease and its association with clinical outcomes.

Marco Antonio Yamazaki-Nakashimada, Luisa Berenise Gámez-González, Chiharu Murata, Takafumi Honda, Kumi Yasukawa, Hiromichi Hamada

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marco Antonio Yamazaki-NakashimadaClinical Immunology Department, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, 04530, Mexico City, Mexico. yzki71@yahoo.com.mx.
Luisa Berenise Gámez-GonzálezDepartment of Allergy and Clinical Immunology, Hospital Infantil de Especialidades de Chihuahua, Chihuahua, Mexico.
Chiharu MurataResearch Unit, Instituto Nacional de Pediatría, Mexico City, Mexico.
Takafumi HondaDepartment of Pediatrics, Yachiyo Medical Center, Tokyo Women's Medical University, Yachiyo, Chiba, Japan.
Kumi YasukawaDepartment of Pediatrics, Yachiyo Medical Center, Tokyo Women's Medical University, Yachiyo, Chiba, Japan.
Hiromichi HamadaDepartment of Pediatrics, Yachiyo Medical Center, Tokyo Women's Medical University, Yachiyo, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have suggested an association of IgG levels (before and after IVIG infusion) with clinical outcomes in Kawasaki disease. A retrospective analysis was performed that included 418 patients with KD admitted to Tokyo Women's Medical University Yachiyo Medical Center to evaluate pre- and post-IVIG IgG levels and its relation to outcomes. All patients received an initial IVIG infusion and aspirin; IgG levels were measured in 350 patients before IVIG (pre-IVIG IgG levels) and in 373 patients 48 h after starting IVIG infusion (post-IVIG IgG levels). Media and standard deviation of the pre- and post-IVIG IgG levels were reported and classified according to age. Also, IgG z-scores were calculated according to normal values of IgG by age. The number of cases and corresponding percentage of non-responders were reported by age and total patients. The association of pre-IVIG, post-IVIG IgG levels and post-IVIG IgG level/pre-IVIG IgG level ratio with no-response was evaluated by simple logistic regression model based on the IgG z-score, and regression coefficient, X

Indexed as

AspirinChildChild, PreschoolCyclosporineFemaleHumansImmunoglobulin GImmunoglobulins, IntravenousImmunologic FactorsImmunosuppressive AgentsInfantLogistic ModelsMaleMucocutaneous Lymph Node SyndromePlatelet Aggregation InhibitorsPrognosisAspirinCyclosporineImmunoglobulin GImmunoglobulins, IntravenousImmunologic FactorsImmunosuppressive AgentsPlatelet Aggregation InhibitorsIgGIgG levelsIntravenous immunoglobulinsKawasaki disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.